Understanding Patients' Awareness, Perspectives, and Approaches to Managing Dry Eye Disease - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Understanding Patients' Awareness, Perspectives, and Approaches to Managing Dry Eye Disease

  • By

  • Chongyan Zhu

  • Yajie Zhou

  • Hongwei Zhou

  • December 29, 2025

Share

Clinical Scorecard: Understanding Patients' Awareness, Perspectives, and Approaches to Managing Dry Eye Disease

At a Glance

CategoryDetail
ConditionDry Eye Disease (DED)
Key MechanismsCharacterized by ocular discomfort, visual disturbances, and tear film instability.
Target PopulationPatients aged 18 years and older diagnosed with dry eye disease.
Care SettingOutpatient settings, particularly in ophthalmology.

Key Highlights

  • Global prevalence of DED is approximately 11.59%; in China, it is 13.55%.
  • High prevalence of symptomatic DED among Chinese high school students at 70.5%.
  • Patients' awareness of DED symptoms is crucial for effective disease management.
  • Adherence to treatments like artificial tears and anti-inflammatory medications improves prognosis.
  • Knowledge, attitudes, and practices (KAP) study is essential for understanding patient responses.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis based on symptoms and objective examinations including TBUT, Schirmer I test, and fluorescein staining.

Management

  • Utilization of artificial tears and anti-inflammatory medications based on disease severity.

Monitoring & Follow-up

  • Regular follow-up visits to enhance treatment adherence and patient confidence.

Risks

  • Increased psychological distress due to ocular discomfort and visual impairment.

Patient & Prescribing Data

Patients diagnosed with dry eye disease aged 18 and older.

Access to treatment may be influenced by medical insurance coverage.

Clinical Best Practices

  • Implement educational interventions to improve patient knowledge about DED.
  • Encourage proactive treatment approaches and adherence to prescribed therapies.
  • Conduct regular assessments of patient attitudes and practices regarding DED management.

Related Resources & Content

Original Source(s)

Related Content